Alzheimer Disease Therapeutics Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com
Dallas, TX (PRWEB) March 03, 2015 -- The report “Alzheimer’s Disease – Pipeline Review, H1 2015″ provides comprehensive information on the therapeutic development for Alzheimer’s Disease. Alzheimer’s disease is a type of dementia that causes problems with memory, thoughts and activities. The Alzheimer’s disease starts mild and gets gradually worse. It is the most common cause of dementia. Signs and symptoms include memory loss, thinking problems, poor judgment, loss of spontaneity, sense of initiative, mood and personality changes, increased aggression, increased sleeping and irritability. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/alzheimers-disease-pipeline-review-h1-2015-market-report.html .
The report also reviews key players involved in the therapeutic development for alzheimer’s disease and special features on late-stage and discontinued projects. Companies discussed in this Alzheimer’s Disease – Pipeline Review, H1 2015 report include AB Science, AbbVie Inc., AC Immune SA, Acadia Pharmaceuticals Inc., Acelot, Inc., Acumen Pharmaceuticals, Inc., Adamas Pharmaceuticals, Inc., Addex Therapeutics Ltd, AFFiRiS AG, Alector LLC, ALSP, Inc., Alzhyme Pty Ltd, Alzinova AB, AlzProtect SAS
Amarantus Bioscience Holdings, Inc., Amgen Inc., Anavex Life Sciences Corp., Angita B.V., Apodemus AB,
Araclon Biotech, S.L., Archer Pharmaceuticals, Inc., ArmaGen Technologies, Inc., Artery Therapeutics, Inc., Astellas Pharma Inc., AstraZeneca PLC, Ausio Pharmaceuticals, LLC, Avergen Ltd, Avineuro Pharmaceuticals, Inc., Axerion Therapeutics, Inc., Axon Neuroscience SE, Axxam SpA, Azevan Pharmaceuticals, Inc., BioArctic Neuroscience AB, biOasis Technologies Inc., Biogen Idec Inc., Biomar Microbial Technologies, Bionature E.A. Ltd., Biotie Therapies Corp., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Bsim2, CalAsia Pharmaceuticals, Inc., Cardax Pharmaceuticals, Inc., Celon Pharma Sp. z o.o., CHA Bio & Diostech Co., Ltd., Chase Pharmaceuticals Corporation, Clera Inc., Cognition Therapeutics, Inc., Cognosci, Inc., CoLucid Pharmaceuticals, Inc., CoMentis, Inc., Cortica Neurosciences, Inc., Critical Outcome Technologies Inc., CrystalGenomics, Inc., D-Pharm Ltd., Daewoong Pharmaceutical Co., Ltd., Delenex Therapeutics AG, DermaXon, LLC, Domain Therapeutics SA, Echo Pharmaceuticals B.V., Eisai Co., Ltd., Eli Lilly and Company, EncephRx, Inc., EndoCeutics, Inc., Epigen Biosciences, Inc., Eucalyptus Ltd., Euroscreen S.A., Evotec AG, F. Hoffmann-La Roche Ltd., FORUM Pharmaceuticals Inc., Galantos Pharma GmbH, Genentech, Inc., Genervon Biopharmaceuticals, LLC, GlaxoSmithKline plc, GliaCure Inc., Grifols, S.A., H. Lundbeck A/S, High Point Pharmaceuticals, LLC, Humanetics Corporation, Ichor Medical Systems, Inc., Icure Pharmaceutical Inc., IMMD Inc., Immunome Inc., ImStar Therapeutics Inc., Inovio Pharmaceuticals, Inc., Intellect Neurosciences, Inc., Intra-Cellular Therapies, Inc, etc.
Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=308873 . (This is a premium report priced at US$2500 for a single user License.)
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of content
Table of Contents
Table of Contents 2
Introduction 11
Alzheimer's Disease Overview 12
Therapeutics Development 13
Alzheimer's Disease - Therapeutics under Development by Companies 15
Alzheimer's Disease - Therapeutics under Investigation by Universities/Institutes 33
Alzheimer's Disease - Pipeline Products Glance 41
Alzheimer's Disease - Products under Development by Companies 45
Alzheimer's Disease - Products under Investigation by Universities/Institutes 73
Alzheimer's Disease - Companies Involved in Therapeutics Development 83
Alzheimer's Disease - Therapeutics Assessment 285
Drug Profiles 306
Alzheimer's Disease - Recent Pipeline Updates 968
Alzheimer's Disease - Dormant Projects 1089
Alzheimer's Disease - Discontinued Products 1122
Alzheimer's Disease - Product Development Milestones 1132
Appendix 1138
List of Tables
Number of Products under Development for Alzheimer's Disease, H1 2015
Number of Products under Development for Alzheimer's Disease - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Explore more reports on Alzheimer Drugs Market at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment/alzheimer-drugs .
About Us:
RnRMarketResearch.com is a database of selected syndicated market reports for global and China industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.
Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article